Smad3 | SMAD family member 3
Physiological systems
16 / 24 physiological systems tested
4 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system Mortality/aging
12 No significant impact
8 Not tested
Data collections
Gene metrics:3Significant phenotypes
4Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
preweaning lethality, complete penetrance | 1 supporting dataset | Smad3em1(IMPC)H | homozygote | Early adult | N/A * | ||
decreased circulating alkaline phosphatase level | 1 supporting dataset | Smad3em1(IMPC)H | heterozygote | Early adult | 5.92x10-6 | ||
decreased lymphocyte cell number | 1 supporting dataset | Smad3em1(IMPC)H | heterozygote | Early adult | 1.04x10-6 |
| | | | | | | | | |
External links
No external links available for Smad3.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Smad3em1(IMPC)H | Indel | | mouse |
Smad3tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Smad3tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |